“Our in-depth examination of these reports is continuing,” Agence France-Presse quoted agency director John Ryan as saying.
In France, the Medicines Safety Agency announced that it had detected two new deaths due to blood clots in two people who received the vaccine.AstraZeneca“.
A report by the agency indicated that, during the period between 19 and 25 March, it detected 3 cases of blood clots after vaccination with the “AstraZeneca” vaccine, which resulted in two deaths.
Since the beginning of the vaccination campaign in France, 12 cases of blood clots have been reported, resulting in 4 deaths.
It is noteworthy that a number of countries, most of which are members of the European Union, have suspended the use of the “AstraZeneca” vaccine due to reports about blood clots in people who have received the vaccine, but the European Medicines Agency, after conducting additional studies, has not detected any direct link between these cases and the vaccine.
The use of the vaccine in general resumed in most countries, while certain countries maintained some restrictions on the use of the vaccine.